To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieu
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm 14152, Sweden.
Centre for Chemistry and Drug Discovery, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia.
Show others and affiliations
2025 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 122, no 6, article id e2414230122Article in journal (Refereed) Published
Abstract [en]

Mucosal-associated invariant T (MAIT) cells are unconventional T cells that mediate rapid antimicrobial immune responses to antigens derived from microbial riboflavin pathway metabolites presented by the evolutionarily conserved MR1 molecules. MAIT cells represent a large pre-expanded T cell subset in humans and are involved in both protective immunity and inflammatory immunopathology. However, what controls the functional heterogeneity of human MAIT cell responses is still largely unclear. Here, combining functional and transcriptomic analyses, we investigate how MAIT cell response programs are influenced by the cytokine milieu at the time of antigen recognition. Activation by MR1-presented antigen together with IL-12 induces intermediate levels of IFNγ and TNF, as well as a regulatory profile with substantial IL-10 production and elevated expression of TIM-3, LAG-3, and PD-1. Activation by the combination of antigen and IL-12 induces a c-MAF-dependent program required for IL-10 production. The MAIT cell-derived IL-10 mediates both autocrine and paracrine immune regulation. In contrast, coactivation of MAIT cells with IL-18 induces IL-17, GM-CSF, IFNγ, and TNF, without IL-10. Notably, IL-18 dominantly counteracts IL-10 expression. The activation states biased toward IL-10 or IL-17 production are reversible and do not represent stable subsets. Finally, MR1-restricted TCR-mediated activation without cytokine coactivation drives primarily granzyme B cytolytic arming. Altogether, these findings demonstrate that human MAIT cells adapt their functional effector response during antigen recognition to cytokine cues in the microenvironment, and identify programs biased toward either regulatory c-MAF-dependent IL-10 expression, or an inflammatory IL-17 and GM-CSF profile.

Place, publisher, year, edition, pages
Proceedings of the National Academy of Sciences (PNAS), 2025. Vol. 122, no 6, article id e2414230122
Keywords [en]
IL-10, MAIT cells, MR1, T cells, human
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-119115DOI: 10.1073/pnas.2414230122ISI: 001459599300013PubMedID: 39903121Scopus ID: 2-s2.0-85218035406OAI: oai:DiVA.org:oru-119115DiVA, id: diva2:1935291
Funder
Swedish Research Council, 2020-01743Swedish Research Council, 2023-02857Swedish Cancer Society, 20-1142PjFSwedish Cancer Society, 23-2912PjSwedish Heart Lung Foundation, 2021044722Swedish Heart Lung Foundation, 20230551Karolinska Institute
Note

Funding:

This research was supported by grants to J.K.S. from the Swedish Research Council (2020-01743, 2023-02857), the Swedish Cancer Society (20-1142PjF, 23-2912Pj), the Swedish Heart-Lung Foundation (2021044722, 20230551), the Center for Innovative Medicine (FoUI-989096) and Karolinska Institutet. T.R.M. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 496946670. D.P.F. and J.Y.W.M. were supported by Australian National Health and Medical Research Council Leadership Investigator (2009551), Australian Research Council (CE200100012), and US NIH R01 (AI148407) grants.

Available from: 2025-02-06 Created: 2025-02-06 Last updated: 2025-04-15Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Halfvarson, Jonas

Search in DiVA

By author/editor
Halfvarson, Jonas
By organisation
School of Medical Sciences
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 23 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf